![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 2")
Safety and Efficacy of MAOIs in Patients Using Psychoactive Substances
Monoamine oxidase inhibitors drug interactions safety is crucial for patients using psychoactive substances. This review highlights the relative safety of MAOIs in such patients. Careful monitoring and individualized assessment are essential for optimal…
Cannabis effects on cardiovascular health: Evidence, gaps, and future directions
Cannabis cardiovascular safety concerns are increasingly important as use expands globally. Current evidence shows mixed results but a stronger link to atrial arrhythmias. This review highlights critical gaps in knowledge and the need for cautious…
Investigating Medicinal Cannabis for Muscle Spasticity and Spasms
This muscle spasticity cannabis study evaluates the effectiveness and adverse events of medicinal cannabis in patients with muscle spasticity or spasms. CBD-only products showed meaningful improvements in sleep disturbance, fatigue, and pain interference…
Cannabidiol and Cannabigerol Ameliorate Steatotic Liver Disease
Cannabidiol and cannabigerol fatty liver effects show promise in improving metabolic liver disease. These cannabinoids work through phosphocreatine buffering and lysosomal restoration. This study highlights their potential therapeutic roles in steatotic…
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
This study investigates cannabis cognitive effects multiple sclerosis patients experience, revealing discrepancies between subjective complaints and objective testing. Cannabis users with MS report greater perceived cognitive deficits than non-users.…
Medical Cannabis and Epilepsy: Reviewing the Evidence
Cannabis epilepsy treatment evidence highlights the anticonvulsant properties of CBD and THC in managing seizures. Approximately 30% of epilepsy patients have drug-resistant forms that may benefit from cannabis-based therapies. Understanding this…
Understanding Cannabis Knowledge Gaps in Emergency Department Patients
This study highlights emergency department cannabis knowledge gaps between users and non-users. Understanding these gaps can improve patient education and clinical care. Emergency physicians benefit from targeted approaches to cannabis discussions.
Investigational Drugs in PTSD: Emerging Clinical Evidence
The endocannabinoid system and PTSD clinical evidence reveal promising investigational drugs targeting neurobiological pathways. PTSD remains challenging with limited FDA-approved options. Emerging treatments like ketamine and cannabinoids offer hope for…
Medical Cannabis Use in Autism: Patient Characteristics and Guidelines
This study examines medical cannabis prescribing patterns autism in a large Israeli HMO. It highlights patient characteristics and alignment with national guidelines. Evidence for medical cannabis use in autism remains limited but growing.
Exploring Patient Views on Off-Label Cannabidiol Use for Insomnia
This study examines patient perceptions of off-label cannabidiol use for insomnia through sentiment analysis. It offers insights into real-world experiences beyond clinical trials. Understanding these perceptions helps inform cautious clinical guidance…